No decision will be made on whether to consolidate all Darvocet lawsuits filed in federal courts until at least July, the U.S. Judicial Panel on Multidistrict Legislation has decided, believing further arguments must be heard before a final decision is made on the matter. The motion to centralize the lawsuits under one judge as part of a multidistrict litigation (MDL) was originally filed in December 2010, less than a month after the Food and Drug Administration banned Darvocet, Darvon, and other propoxyphene-based generics. However, after listening to arguments in a March hearing, the judges on the MDL panel pushed back ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.